Vicus Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Buy
584
+68
+13% +$69.5K 0.05% 163
2026
Q1
$475K Buy
516
+47
+10% +$47.6K 0.03% 181
2025
Q4
$504K Buy
469
+55
+13% +$52.6K 0.04% 182
2025
Q3
$316K Buy
414
+33
+9% +$24.6K 0.02% 215
2025
Q2
$297K Sell
381
-132
-26% -$103K 0.02% 215
2025
Q1
$424K Sell
513
-35
-6% -$29.1K 0.04% 155
2024
Q4
$423K Buy
548
+104
+23% +$86.1K 0.04% 149
2024
Q3
$393K Sell
444
-381
-46% -$343K 0.03% 157
2024
Q2
$747K Sell
825
-36
-4% -$28.8K 0.07% 114
2024
Q1
$670K Buy
861
+314
+57% +$223K 0.06% 123
2023
Q4
$319K Sell
547
-430
-44% -$251K 0.03% 162
2023
Q3
$525K Buy
977
+430
+79% +$222K 0.06% 140
2023
Q2
$256K Buy
+547
New +$229K 0.03% 184
2023
Q1
Sell
-684
Closed -$250K 211
2022
Q4
$250K Sell
684
-261
-28% -$92.5K 0.03% 176
2022
Q3
$305K Buy
945
+155
+20% +$49.1K 0.04% 170
2022
Q2
$256K Buy
790
+83
+12% +$24.9K 0.03% 186
2022
Q1
$202K Buy
+707
New +$182K 0.02% 221

Other funds holding LLY

Vicus Capital's LLY Position: Q2 2026 in Review

Vicus Capital increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $69.5K and bringing the position to 584 shares worth $700K. The position accounts for 0.05% of the portfolio, ranked #163.

Vicus Capital first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $747K in Q2 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vicus Capital held 584 shares of Eli Lilly worth $700K as of Q2 2026.
  • Vicus Capital bought 68 Eli Lilly shares in Q2 2026, an estimated $69.5K.
  • Eli Lilly made up 0.05% of Vicus Capital's portfolio in Q2 2026, its #163 holding.
  • Vicus Capital first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • Vicus Capital's Eli Lilly position peaked at $747K in Q2 2024.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vicus Capital's 13F filing for Q2 2026, filed 5 Aug 2026.